Basic HIV Vaccine Discovery Research

Agency: 
NIH

The purpose of this initiative is to support a broad range of research in basic disciplines including immunology, virology, cellular and structural biology and host genetics that potentially can lead to new discoveries, expanded knowledge, and novel concepts and approaches applicable to the design of an effective prophylactic HIV-1 vaccine. Applications must clearly demonstrate how the proposed research will directly contribute to the design of an effective prophylactic HIV-1 vaccine that prevents infection and/or substantially ameliorates the progression of disease.

Deadline: 
October 9, 2009

Last updated June 12, 2009